Inflammation is deeply related with tumor development and progression, and the importance of immunological and nutritional laboratory markers as well as prognostic scores, considering serum albumin, neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), systemic immune inflammation index (SII), has already been investigated in different tumours and also in NSCLC treated with immunotherapy [43,44] or target therapies. Here, ALB is linked to neoplasm.